MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 37 filers reported holding MAST THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,000 | +50.0% | 46,631 | +0.6% | 0.00% | – |
| Q4 2016 | $4,000 | -20.0% | 46,353 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -77.3% | 46,353 | -1.0% | 0.00% | – |
| Q2 2016 | $22,000 | +22.2% | 46,800 | +47.1% | 0.00% | – |
| Q3 2015 | $18,000 | +28.6% | 31,807 | +14.3% | 0.00% | – |
| Q2 2015 | $14,000 | +7.7% | 27,835 | 0.0% | 0.00% | – |
| Q1 2015 | $13,000 | +8.3% | 27,835 | +32.2% | 0.00% | – |
| Q4 2014 | $12,000 | +71.4% | 21,059 | +57.3% | 0.00% | – |
| Q3 2014 | $7,000 | -75.0% | 13,388 | -70.0% | 0.00% | – |
| Q2 2014 | $28,000 | -15.2% | 44,580 | -9.1% | 0.00% | – |
| Q1 2014 | $33,000 | +83.3% | 49,036 | +29.4% | 0.00% | – |
| Q4 2013 | $18,000 | +12.5% | 37,890 | +6.3% | 0.00% | – |
| Q3 2013 | $16,000 | +6.7% | 35,639 | 0.0% | 0.00% | – |
| Q2 2013 | $15,000 | – | 35,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,442,400 | $2,390,000 | 1.66% |
| Ancora Advisors LLC | 1,848,045 | $811,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 3,639,571 | $1,598,000 | 0.10% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,668,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,634,221 | $1,156,000 | 0.05% |
| SHEPHERD KAPLAN KROCHUK, LLC | 602,776 | $265,000 | 0.04% |
| PERKINS CAPITAL MANAGEMENT INC | 110,000 | $48,000 | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 2,900,000 | $1,273,000 | 0.00% |
| FRANKLIN RESOURCES INC | 12,046,100 | $5,288,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 200,000 | $88,000,000 | 0.00% |